Cslbehring.sk - Global Biotechnology Company | CSL
Provided by Alexa ranking,
cslbehring.sk has ranked
N/A in
N/A and
1,163,407 on the world.
cslbehring.sk reaches roughly
2,689 users per day and delivers about
80,667 users each month. The domain cslbehring.sk uses a Commercial suffix and it's server(s) are located in
N/A with the IP number
12.3.33.229 and it is a
.sk domain.
WEBCSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas.
List of domain same IP 12.3.33.229
Search Results related to cslbehring.sk on Search Engine
-
Global Biotechnology Company | CSL
https://www.csl.com/we-are-csl/our-businesses-and-products/csl-behring
WEBCSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas.
DA: 60 PA: 33 MOZ Rank: 58
-
Global Biotechnology Company | CSL
https://www.csl.com/
WEBCSL Behring. Leading the Way in Treating Rare and Serious Diseases. CSL Behring is a global biotech leader with a broad range of biotherapies for rare and serious diseases including bleeding disorders, immunodeficiencies, hereditary angioedema, neurological disorders and Alpha 1 Antitrypsin Deficiency.
DA: 41 PA: 22 MOZ Rank: 49
-
CSL Behring - Wikipedia
https://en.wikipedia.org/wiki/CSL_Behring
WEBCSL Behring is a biopharmaceutical company, manufacturing plasma-derived, and recombination therapeutic products. The company is a combination of Behringwerke, founded in 1904 in Marburg , Germany by Emil von Behring , and the Commonwealth Serum Laboratories (CSL), established in Australia in 1916 to provide vaccines to the people of …
DA: 77 PA: 51 MOZ Rank: 17
-
We Are CSL | CSL
https://www.csl.com/we-are-csl
WEBCSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients' needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas.
DA: 99 PA: 71 MOZ Rank: 7
-
Our Company - CSL Behring
https://www.cslbehring.ch/en-us/our-company
WEBMore than 100 years ago, CSL was formed to save lives using the latest technologies. In the century since, CSL Behring has grown into a global biotechnology leader, driven by that same promise to save and improve lives. We offer the broadest range of quality plasma-derived and recombinant therapies in our industry.
DA: 31 PA: 84 MOZ Rank: 30
-
Our Company - CSL Behring
https://www.cslbehring.de/en-us/our-company
WEBWhat Drives Us. Commitment to the well-being of our patients – that’s what we stand for at CSL Behring Marburg. As a global biotechnology company and major employer in Middle Hesse, we work every day for our patients around the world and do so with smiles on our faces. Learn More.
DA: 19 PA: 30 MOZ Rank: 22
-
Products - CSL Behring
https://www.cslbehring.ch/en-us/products
WEBProducts. CSL Behring Switzerland. Products. Our Products. We specialise in the manufacture of biotherapeutic products, with more than a century of experience in the treatment of various diseases worldwide. In contrast to chemically manufactured pharmaceuticals, biotherapeutic products are manufactured from human plasma or by …
DA: 87 PA: 86 MOZ Rank: 56
-
Global Newsroom | CSL
https://newsroom.csl.com/
WEBFeb 12, 2024 - Strong CSL Behring portfolio growth especially Ig FINANCIAL HIGHLIGHTS4 Revenue $8.05 billion, up 11% at CC3 NPAT $1.90 billion1, up 17% NPAT $1.94 billion1 at CC3, up 20% NPATA $2.02 billion1,2 ,... Read more news from CSL. CSL Behring.
DA: 92 PA: 11 MOZ Rank: 32
-
CSL Behring Announces the First Patient Has Received FDA …
https://newsroom.csl.com/2023-06-20-CSL-Behring-Announces-the-First-Patient-Has-Received-FDA-Approved-HEMGENIX-R-etranacogene-dezaparvovec-drlb-for-Hemophilia-B
WEBKING OF PRUSSIA, Pa., June 20, 2023 / PRNewswire / -- Global biotechnology leader CSL Behring today announced that the first patient has received U.S. Food and Drug Administration (FDA) approved HEMGENIX ® (etranacogene dezaparvovec-drlb) for hemophilia B in the United States.
DA: 6 PA: 21 MOZ Rank: 24
-
Our Story - CSL Behring
https://www.cslbehring.ch/en-us/our-company/our-story
WEBOur Story. CSL Behring Switzerland. Our Company. Our Story. CSL Behring – a specialist in biotherapeutics for more than 100 years. Our 100th anniversary video tells you everything you need to know about our promise to our patients. 2021 Operating licence and start of production at CSL Behring Lengnau AG.
DA: 64 PA: 74 MOZ Rank: 73
Alexa Rank
GLOBAL RANK
Alexa Reach
Page length
Alexa Rank Country N/A
Daily Unique Visitors
Monthly Unique Visitors
Vistor via Country
Country lang
Country code
Total visitor
Country
Country code
Total visitor
Alexa Traffic Graph
Alexa daily traffic trend graph
Alexa daily pageviews (percent) graph
Alexa daily pageviews per user graph
Alexa time on site (in minutes) graph
Alexa bounce rate (percent) graph
Alexa search visits graph
SEOquake Zone
Title |
|
|
Tips |
Description |
|
|
Tips |
Keywords |
|
|
Tips |
Viewport |
|
|
Tips |
Icon |
|
|
|
UTF-8 |
|
|
|
Mini site formation by Alexa Rank
DNS Record
Host |
Type |
Class |
TTL |
Extra |
Hosting and Whois Zone
IP |
12.3.33.229 |
Domain infomation |
Domain: cslbehring.sk Created: 2019-07-18 Valid Until: 2025-07-18 Updated: 2023-08-31 Domain Status: clientTransferProhibited, clientUpdateProhibited, clientDeleteProhibited Nameserver: dmtu.mt.ns.els-gms.att.net Nameserver: dbru.br.ns.els-gms.att.net
Domain registrant: mmr-81248 Name: Domain Administrator Organization: CSL Behring GmbH Organization ID: HRB1056 Phone: +49.64213912 Email: [email protected] Street: Emil-von-Behring-Strasse 76 City: Marburg Postal Code: 35041 Country Code: DE Authorised Registrar: MARK-0292 Created: 2019-05-22 Updated: 2019-05-22
Registrar: MARK-0292 Name: MarkMonitor International Limited Organization: MarkMonitor International Limited Organization ID: 4847541 Phone: +1.2083895740 Email: [email protected] Street: 12 New Fetter Lane City: London Postal Code: EC4A 1JP Country Code: UK Created: 2018-06-27 Updated: 2024-02-29
Administrative Contact: mmr-81248 Name: Domain Administrator Organization: CSL Behring GmbH Organization ID: HRB1056 Phone: +49.64213912 Email: [email protected] Street: Emil-von-Behring-Strasse 76 City: Marburg Postal Code: 35041 Country Code: DE Created: 2019-05-22 Updated: 2019-05-22
Technical Contact: mmr-81248 Name: Domain Administrator Organization: CSL Behring GmbH Organization ID: HRB1056 Phone: +49.64213912 Email: [email protected] Street: Emil-von-Behring-Strasse 76 City: Marburg Postal Code: 35041 Country Code: DE Created: 2019-05-22 Updated: 2019-05-22
|